NuScale Power Is Down 84% From Its 52-Week High. Is It Finally Time to Buy the Dip in the Nuclear Start-Up?

NuScale Power is the only U.S.-NRC-design-approved small modular reactor (SMR) player, but its competitive edge has eroded as the Department of Energy’s Reactor Pilot Program aims to compress licensing timelines from “several years” to ~18 months. The company has one Romania project with six 77 MWe modules targeted by 2033, while a potential deal with the Tennessee Valley Authority (up to 6 GW) is not yet firm—despite management aiming to finalize by year-end. The stock is down ~84–85% from its $57.42 peak, reflecting high risk from limited signed commitments and faster competitor approvals.

Analysis

The market is likely still overpaying for the idea that regulatory approval equals defensibility. Once licensing timelines compress, the scarce asset shifts from “approved design” to “bankable counterparties, EPC execution, and project finance,” which is a much tougher moat to own and far easier to copy. That means SMR’s valuation should be tied less to optionality headlines and more to the probability-weighted conversion of one or two large contracts into funded orders.

The second-order winner is not necessarily SMR, but the hyperscalers that need power certainty. If advanced nuclear lowers long-dated grid-congestion risk, the real beneficiaries are MSFT, GOOGL, and META through lower execution risk on data-center buildouts and stronger negotiating leverage versus utilities and renewables developers. The losers are smaller “concept” reactor names and any supplier basket priced for a scarcity premium on licensing lead times; that premium should compress as the regulatory path normalizes.

Near term, this is a catalyst trade, not a fundamentals inflection. The end-year contract target is the only meaningful upside trigger; absent a binding customer, financing structure, and EPC visibility, the stock remains a narrative vehicle. The contrarian view is that the recent selloff may not be done, because the market is only now starting to discount execution risk rather than celebrate policy rhetoric; if the TVA process slips or comes back as non-binding, the rerating could be sharp.

Falsifiers: a signed, financeable utility or hyperscaler agreement; proof that the pilot program materially shortens time-to-FID; or a broader reacceleration in nuclear capital formation across peers.

Key Decisions for Investors

• Short SMR on any rally tied to licensing/pilot-program headlines; use a 1-3 month horizon and cover only if a binding customer contract or project financing package is announced.
• If you want AI power exposure, prefer MSFT/GOOGL/META over SMR; the option value is in demand growth and bargaining power, not in owning the reactor developer.
• Use SMR put spreads into year-end catalyst windows rather than outright short stock if borrow is tight; risk/reward improves if the market bids up the name on deal speculation.
• Set an alert for a signed TVA-style commitment: if it is non-binding or delayed, add to the short; if fully financed, thesis breaks and the trade should be exited immediately.